Scholarlink

<p>This work presents a novel “off-on” fluorescent nanosensor for detecting apoptosis and evaluating chemotherapy efficacy in osteosarcoma. The sensor is constructed by conjugating carboxyl-modified CdTe quantum dots (CdTe QDs) to a BHQ1-labeled peptide substrate containing the caspase-3-specific DEVD sequence. Caspase-3 activation, a hallmark of apoptosis, cleaves the peptide, releasing the BHQ1 quencher and restoring QD fluorescence. The sensor demonstrated high sensitivity and selectivity for caspase-3, excellent stability, and minimal cytotoxicity. Applied to cell lysates, the sensor effectively detected chemotherapy-induced apoptosis in osteosarcoma cells, showing a dose-dependent fluorescence response to cisplatin and doxorubicin treatment that correlated with drug efficacy. Notably, the sensor revealed significantly higher baseline caspase-3 activity in osteosarcoma cells compared to normal osteoblasts, and enabled quantitative monitoring of apoptotic response upon drug treatment. This platform offers a promising tool for osteosarcoma theranostics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

An “off-on” CdTe QDs fluorescent nanosensor for detecting apoptosis in osteosarcoma and evaluating chemotherapy response

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月24日

查看全文
  • Dongdong Lu,
  • Zhenggang Tan,
  • Yun Gao,
  • Binxu Han,
  • Zhengjun Bian

摘要

This work presents a novel “off-on” fluorescent nanosensor for detecting apoptosis and evaluating chemotherapy efficacy in osteosarcoma. The sensor is constructed by conjugating carboxyl-modified CdTe quantum dots (CdTe QDs) to a BHQ1-labeled peptide substrate containing the caspase-3-specific DEVD sequence. Caspase-3 activation, a hallmark of apoptosis, cleaves the peptide, releasing the BHQ1 quencher and restoring QD fluorescence. The sensor demonstrated high sensitivity and selectivity for caspase-3, excellent stability, and minimal cytotoxicity. Applied to cell lysates, the sensor effectively detected chemotherapy-induced apoptosis in osteosarcoma cells, showing a dose-dependent fluorescence response to cisplatin and doxorubicin treatment that correlated with drug efficacy. Notably, the sensor revealed significantly higher baseline caspase-3 activity in osteosarcoma cells compared to normal osteoblasts, and enabled quantitative monitoring of apoptotic response upon drug treatment. This platform offers a promising tool for osteosarcoma theranostics.